Telemus Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,044
Closed -$997K 421
2019
Q3
$997K Buy
10,044
+500
+5% +$47.5K 0.08% 176
2019
Q2
$886K Sell
9,544
-4,438
-32% -$421K 0.08% 175
2019
Q1
$1.32M Sell
13,982
-18,734
-57% -$1.64M 0.1% 156
2018
Q4
$2.1M Buy
32,716
+3,074
+10% +$227K 0.17% 110
2018
Q3
$2.65M Buy
29,642
+226
+0.8% +$20K 0.2% 106
2018
Q2
$2.34M Buy
29,416
+1,139
+4% +$94.6K 0.18% 109
2018
Q1
$2.52M Buy
28,277
+2,154
+8% +$207K 0.2% 100
2017
Q4
$2.73M Buy
26,123
+574
+2% +$64.8K 0.21% 94
2017
Q3
$3.73M Sell
25,549
-1,853
-7% -$252K 0.42% 53
2017
Q2
$3.56M Sell
27,402
-14,896
-35% -$1.83M 0.36% 62
2017
Q1
$5.26M Sell
42,298
-4,814
-10% -$576K 0.55% 34
2016
Q4
$5.45M Buy
47,112
+632
+1% +$70.4K 0.74% 25
2016
Q3
$4.86M Sell
46,480
-816
-2% -$88.3K 0.54% 30
2016
Q2
$4.67M Sell
47,296
-4,745
-9% -$491K 0.58% 29
2016
Q1
$5.21M Buy
52,041
+24,864
+91% +$2.56M 0.87% 24
2015
Q4
$3.25M Sell
27,177
-290
-1% -$33.6K 0.88% 29
2015
Q3
$2.97M Buy
27,467
+111
+0.4% +$13.8K 0.77% 23
2015
Q2
$3.17M Sell
27,356
-1,866
-6% -$213K 0.8% 19
2015
Q1
$3.37M Sell
29,222
-972
-3% -$116K 0.82% 18
2014
Q4
$3.38M Sell
30,194
-1,171
-4% -$123K 0.81% 28
2014
Q3
$2.97M Sell
31,365
-635
-2% -$57.3K 0.81% 27
2014
Q2
$2.75M Sell
32,000
-730
-2% -$55.5K 0.72% 29
2014
Q1
$2.29M Sell
32,730
-454
-1% -$36K 0.63% 39
2013
Q4
$2.8M Sell
33,184
-446
-1% -$35.3K 0.81% 25
2013
Q3
$2.59M Buy
+33,630
New +$2.36M 0.77% 26

Other funds holding CELG

Telemus Capital's CELG Position: Q4 2019 in Review

Telemus Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,044 shares — an estimated $997K sold.

Telemus Capital first reported a position in CELG in Q3 2013 and held it in 25 quarters. The position peaked at $5.45M in Q4 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Telemus Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Telemus Capital sold 10,044 Celgene Corp shares in Q4 2019, an estimated $997K.
  • Telemus Capital first reported a position in Celgene Corp in Q3 2013 and held it in 25 quarters.
  • Telemus Capital's Celgene Corp position peaked at $5.45M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Telemus Capital's 13F filing for Q4 2019, filed 24 Jan 2020.